A Clinicopathological Study of Tubo Ovarian Masses at SRMS, IMS, Bareilly, U.P.

article OA: green CC0

Abstract

Background: In gynaecological practise, an adnexal mass is a frequent clinical manifestation. The differential diagnosis of an adnexal mass presents a diagnostic challenge for the treating gynaecologist since it can range from a life-threatening emergency like an ectopic pregnancy to a malignant lesion with a high mortality rate to investigate the histopathology of adnexal masses. Material and Methods: The study comprised 110 cases of adnexal masses that underwent surgical surgery over the course of a year. A specimen that was obtained by the pathology department was examined histopathologically. Results: 110 instances altogether made up the study group. In our analysis, ovarian pathology accounted for 79% of adnexal mass cases, tubal pathology accounted for 15.45%, and combination pathology, or endometriosis and tubovarian abscess, accounted for 5.45%. 9.1% of ovarian lesions were non-neoplastic cysts like corpus luteal cysts or endometriosis, while surface epithelial lesions were present in 50% of cases. Out of a total of 110 cases, 77 were of ovarian origin, with 57 (74%) being benign, 05 (6.5%) borderline, and 15 (19.5%) being malignant. Conclusion: Finally, an adnexal mass frequently presents a diagnostic challenge to the treating doctor. Patients in the reproductive age range who experience adnexal mass frequently have an ectopic pregnancy. The most frequent benign ovarian lesion is a serous cyst adenoma, while the most frequent malignant ovarian lesion is a serous cyst adenocarcinoma. Ovarian neoplasms are another important factor in the development of adnexal masses.
Full text 6,790 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Background

In gynaecological practise, an adnexal mass is a frequent clinical manifestation. The differential diagnosis of an adnexal mass presents a diagnostic challenge for the treating gynaecologist since it can range from a life-threatening emergency like an ectopic pregnancy to a malignant lesion with a high mortality rate to investigate the histopathology of adnexal masses. Material and Methods: The study comprised 110 cases of adnexal masses that underwent surgical surgery over the course of a year. A specimen that was obtained by the pathology department was examined histopathologically. Results: 110 instances altogether made up the study group. In our analysis, ovarian pathology accounted for 79% of adnexal mass cases, tubal pathology accounted for 15.45%, and combination pathology, or endometriosis and tubovarian abscess, accounted for 5.45%. 9.1% of ovarian lesions were non-neoplastic cysts like corpus luteal cysts or endometriosis, while surface epithelial lesions were present in 50% of cases. Out of a total of 110 cases, 77 were of ovarian origin, with 57 (74%) being benign, 05 (6.5%) borderline, and 15 (19.5%) being malignant. Conclusion: Finally, an adnexal mass frequently presents a diagnostic challenge to the treating doctor. Patients in the reproductive age range who experience adnexal mass frequently have an ectopic pregnancy. The most frequent benign ovarian lesion is a serous cyst adenoma, while the most frequent malignant ovarian lesion is a serous cyst adenocarcinoma. Ovarian neoplasms are another important factor in the development of adnexal masses.

Abstract

(English)

Background

In gynaecological practise, an adnexal mass is a frequent clinical manifestation. The differential diagnosis of an adnexal mass presents a diagnostic challenge for the treating gynaecologist since it can range from a life-threatening emergency like an ectopic pregnancy to a malignant lesion with a high mortality rate to investigate the histopathology of adnexal masses. Material and Methods: The study comprised 110 cases of adnexal masses that underwent surgical surgery over the course of a year. A specimen that was obtained by the pathology department was examined histopathologically. Results: 110 instances altogether made up the study group. In our analysis, ovarian pathology accounted for 79% of adnexal mass cases, tubal pathology accounted for 15.45%, and combination pathology, or endometriosis and tubovarian abscess, accounted for 5.45%. 9.1% of ovarian lesions were non-neoplastic cysts like corpus luteal cysts or endometriosis, while surface epithelial lesions were present in 50% of cases. Out of a total of 110 cases, 77 were of ovarian origin, with 57 (74%) being benign, 05 (6.5%) borderline, and 15 (19.5%) being malignant. Conclusion: Finally, an adnexal mass frequently presents a diagnostic challenge to the treating doctor. Patients in the reproductive age range who experience adnexal mass frequently have an ectopic pregnancy. The most frequent benign ovarian lesion is a serous cyst adenoma, while the most frequent malignant ovarian lesion is a serous cyst adenocarcinoma. Ovarian neoplasms are another important factor in the development of adnexal masses. Files IJPCR,Vol14,Issue9,Article75.pdf Files (692.1 kB) | Name | Size | Download all | |---|---|---| | md5:556c641040c34f3edbdca5032a9bcdcd | 692.1 kB | Preview Download | Additional details Dates - Accepted - 2022-09-10 Software - Repository URL - https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue9,Article75.pdf - Development Status - Active

References

- 1. Graham L. ACOG Releases Guidelines on management of adnexal masses. Am Fam Physician. 2008;77(9):1320–3. 2. Soully RE, Young RH, Clement PB. Atlas of Tumor Pathology. In: Tumors of ovary, maldeveloped gonads, fallopian tube and broad ligament. Washington DC: Armed Forces Institute of Pathology; 1999. p. 1–168. 3. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. Cancer J Clin. 2005;55(2):74–108. 4. Bhatla N, Annwen. The world ovarian cancer coalition. Atlas; 2018. 5. Consolidated Report of Population Based Cancer Registries 2001- 2004. National Cancer registry program. Indian Council of Medical Research, Bangalore, 2006. 6. Bhagde AD, Jani SK, Patel MS, Shah SR. An analytical study of 50 women presenting with an adnexal mass. Int J Reprod, Contracept, Obstet Gynecol. 2016;6(1):262–5. 7. Dotlic J, Terzic M, Likic I, Atanackovic J, Ladjevic N. Evaluation of adnexal masses: Correlation between clinical, ultrasound and histopathological findings. Vojnosanitetski Pregled. 2011;68(10):861–6. 8. Radhamani S, Akhila MV. Evaluation of Adnexal Masses. Correlation of Clinical, Sonological and Histopathological findings in adnexal masses. Int J Sci Study. 2017;4(1):88–92. 9. Mittal A, Kundal RK, Kaur K, Mathur M, Sandhu A, Kaushal N. ClinicoPathological Correlation of TuboOvarian Lesions. Ann Int Med Dent Res. 2018;4(3):51–5. 10. Sharadha SO, Sridevi TA, Renukadevi TK, Gowri R, Binayak D, Indra V. Ovarian Masses: Changing Clinico Histopathological Trends. J Obstet Gynecol India. 2015;65(1):34–8. 11. Wasim T, Majrroh A, Siddiq S. Comparison of clinical presentation of benign and malignant Ovarian tumours. J Pak Med Assoc. 2009; 59:18–21. 12. Seemer H, Ramesh K, Marwah P. Clinico-pathological co-relation of tubo ovarian lesions. A study of 75 cases; Research and Review. J Med Health Sci. 2014;3(4):117–26. 13. Tripathi U, Munda G. Study of correlation of ultrasonography with surgical evaluation of adnexal masses: a prospective study. Int J Reprod,Contracept Obstet Gynecol. 2018;7(10):4218–22. 14. Modi D, Rathore GB, Delwadia KN, Goswami HN. Histopathological pattern of neoplastic ovarian leiosns. IAIM. 2016;3(1):51–7. 15. Kumari N, Gupta V, Kumari R, Makhija A. Evaluation of risk of malignancy index as a diagnostic tool in cases with adnexal mass. Int J Reprod, Contracept, Obstet Gynecol. 2016;5(6):1857–61. 16. Parmar P, Sehgal S, Mathur K, Yadav A. Histopathological study of ovarian tumours in tertiary care center. Int J Med Res Prof. 2017;3(2):96–8. 17. Mondal SK, Banyopadhay R, Nag DR, Roychowdhury S, Mondal PK. Histopathological pattern , bilaterality and clinical evaluation of 957 cases of ovarian neoplasm: A 10 year study in a tertiary hospital in eastern india. J Cancer Res Ther. 2011;7(4):433–7. 18. Forae G, Aligbe J. Ovarian Tumors among Nigerian females: A private practice experience in Benin city, Nigeria. Adv Biomed Res. 2016;5(1):61.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T11:13:55.449368+00:00
License: CC0 · commercial use OK